Long-Term Outcomes of Teplizumab in Routine Clinical Care
Public ClinicalTrials.gov record NCT07360080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-Term Outcomes of Participants Treated With Teplizumab in Routine Clinical Care
Study identification
- NCT ID
- NCT07360080
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Interventions
- Teplizumab Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 18, 2026
- Primary completion
- Oct 28, 2035
- Completion
- Oct 28, 2035
- Last update posted
- May 26, 2026
2026 – 2035
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number: 8400003 | Atlanta | Georgia | 30318-2538 | Recruiting |
| Investigative Site Number: 8400004 | Atlanta | Georgia | 30329-3102 | Recruiting |
| Investigative Site Number: 8400002 | Syosset | New York | 11791 | Recruiting |
| Investigational Site Number: 8400005 | Sandy City | Utah | 84093 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07360080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07360080 live on ClinicalTrials.gov.